961 followers
IL-6 and CCL5 pathways promote crosstalk between #TNBC and #lymphatic vessels and enhance of TNBC’s tumor growth and #metastasis. Promising #preclinical results of the maraviroc (#CCR5 inhibitor) plus tocilizumab (anti-IL-6 receptor #antibody) combo #MBC h